.Pharmacolibrary.Drugs.S_SensoryOrgans.S01G_DecongestantsAndAntiallergics.S01GA03_Xylometazoline.Xylometazoline .Pharmacolibrary.Drugs.S_SensoryOrgans.S01G_DecongestantsAndAntiallergics.S01GA03_Xylometazoline.Xylometazoline| name: | Xylometazoline | |
| ATC code: | S01GA03 | route: | intranasal |
| compartments: | 1 | |
| dosage: | 0.1 | mg |
| volume of distribution: | 0.5 | L |
| clearance: | 10 | L/h |
| other parameters in model implementation | ||
Xylometazoline is a topical nasal decongestant, acting as an alpha-adrenergic agonist. It is primarily used to relieve nasal congestion in conditions such as rhinitis, sinusitis, and the common cold. It is approved for short-term use and is widely available over the counter.
Estimated pharmacokinetic parameters for adult population following intranasal administration. No published compartmental population pharmacokinetic studies exist for xylometazoline; values are inferred or estimated based on related information from similar topical nasal decongestants.